Literature DB >> 22954357

Structure-based design of highly selective β-secretase inhibitors: synthesis, biological evaluation, and protein-ligand X-ray crystal structure.

Arun K Ghosh1, Kalapala Venkateswara Rao, Navnath D Yadav, David D Anderson, Navnath Gavande, Xiangping Huang, Simon Terzyan, Jordan Tang.   

Abstract

The structure-based design, synthesis, and X-ray structure of protein-ligand complexes of exceptionally potent and selective β-secretase inhibitors are described. The inhibitors are designed specifically to interact with S(1)' active site residues to provide selectivity over memapsin 1 and cathepsin D. Inhibitor 5 has exhibited exceedingly potent inhibitory activity (K(i) = 17 pM) and high selectivity over BACE 2 (>7000-fold) and cathepsin D (>250000-fold). A protein-ligand crystal structure revealed important molecular insight into these selectivities. These interactions may serve as an important guide to design selectivity over the physiologically important aspartic acid proteases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22954357      PMCID: PMC3493683          DOI: 10.1021/jm3008823

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  24 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  Developing β-secretase inhibitors for treatment of Alzheimer's disease.

Authors:  Arun K Ghosh; Margherita Brindisi; Jordan Tang
Journal:  J Neurochem       Date:  2011-11-28       Impact factor: 5.372

3.  Intramolecular hydrogen bonding: a potential strategy for more bioavailable inhibitors of neuronal nitric oxide synthase.

Authors:  Kristin Jansen Labby; Fengtian Xue; James M Kraus; Haitao Ji; Jan Mataka; Huiying Li; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  Bioorg Med Chem       Date:  2012-02-07       Impact factor: 3.641

Review 4.  Alzheimer's disease: strategies for disease modification.

Authors:  Martin Citron
Journal:  Nat Rev Drug Discov       Date:  2010-05       Impact factor: 84.694

5.  Potent memapsin 2 (beta-secretase) inhibitors: design, synthesis, protein-ligand X-ray structure, and in vivo evaluation.

Authors:  Arun K Ghosh; Nagaswamy Kumaragurubaran; Lin Hong; Sarang Kulkarni; Xiaoming Xu; Heather B Miller; Dandepally Srinivasa Reddy; Vajira Weerasena; Robert Turner; Wanpin Chang; Gerald Koelsch; Jordan Tang
Journal:  Bioorg Med Chem Lett       Date:  2008-01-03       Impact factor: 2.823

6.  Second generation of BACE-1 inhibitors part 3: Towards non hydroxyethylamine transition state mimetics.

Authors:  Nicolas Charrier; Brian Clarke; Leanne Cutler; Emmanuel Demont; Colin Dingwall; Rachel Dunsdon; Julie Hawkins; Colin Howes; Julia Hubbard; Ishrut Hussain; Graham Maile; Rosalie Matico; Julie Mosley; Alan Naylor; Alistair O'Brien; Sally Redshaw; Paul Rowland; Virginie Soleil; Kathrine J Smith; Sharon Sweitzer; Pam Theobald; David Vesey; Daryl S Walter; Gareth Wayne
Journal:  Bioorg Med Chem Lett       Date:  2009-04-05       Impact factor: 2.823

7.  Intramolecular hydrogen bonding in medicinal chemistry.

Authors:  Bernd Kuhn; Peter Mohr; Martin Stahl
Journal:  J Med Chem       Date:  2010-03-25       Impact factor: 7.446

8.  Synthesis of new (-)-bestatin-based inhibitor libraries reveals a novel binding mode in the S1 pocket of the essential malaria M1 metalloaminopeptidase.

Authors:  Geetha Velmourougane; Michael B Harbut; Seema Dalal; Sheena McGowan; Christine A Oellig; Nataline Meinhardt; James C Whisstock; Michael Klemba; Doron C Greenbaum
Journal:  J Med Chem       Date:  2011-03-02       Impact factor: 7.446

9.  Beta-secretase inhibitor GRL-8234 rescues age-related cognitive decline in APP transgenic mice.

Authors:  Wan-Pin Chang; Xiangping Huang; Deborah Downs; John R Cirrito; Gerald Koelsch; David M Holtzman; Arun K Ghosh; Jordan Tang
Journal:  FASEB J       Date:  2010-11-08       Impact factor: 5.191

10.  Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands.

Authors:  Arun K Ghosh; Nagaswamy Kumaragurubaran; Lin Hong; Sarang S Kulkarni; Xiaoming Xu; Wanpin Chang; Vajira Weerasena; Robert Turner; Gerald Koelsch; Geoffrey Bilcer; Jordan Tang
Journal:  J Med Chem       Date:  2007-04-14       Impact factor: 7.446

View more
  11 in total

1.  Highly Selective and Potent Human β-Secretase 2 (BACE2) Inhibitors against Type 2 Diabetes: Design, Synthesis, X-ray Structure and Structure-Activity Relationship Studies.

Authors:  Arun K Ghosh; Margherita Brindisi; Yu-Chen Yen; Emma K Lendy; Satish Kovela; Emilio Leal Cárdenas; Bhavanam Sekhara Reddy; Kalapala Venketeswara Rao; Deborah Downs; Xiangping Huang; Jordan Tang; Andrew D Mesecar
Journal:  ChemMedChem       Date:  2019-02-05       Impact factor: 3.466

2.  Design, synthesis, and X-ray structural studies of BACE-1 inhibitors containing substituted 2-oxopiperazines as P1'-P2' ligands.

Authors:  Arun K Ghosh; Margherita Brindisi; Yu-Chen Yen; Emilio L Cárdenas; Jean-Rene Ella-Menye; Nagaswamy Kumaragurubaran; Xiangping Huang; Jordan Tang; Andrew D Mesecar
Journal:  Bioorg Med Chem Lett       Date:  2017-04-08       Impact factor: 2.823

3.  Identification of a Small Molecule Cyclophilin D Inhibitor for Rescuing Aβ-Mediated Mitochondrial Dysfunction.

Authors:  Koteswara Rao Valasani; Qinru Sun; Du Fang; Zhihua Zhang; Qing Yu; Yaopeng Guo; Jianping Li; Anuradha Roy; Shirley ShiDu Yan
Journal:  ACS Med Chem Lett       Date:  2016-01-06       Impact factor: 4.345

4.  Structure-based design of potent HIV-1 protease inhibitors with modified P1-biphenyl ligands: synthesis, biological evaluation, and enzyme-inhibitor X-ray structural studies.

Authors:  Arun K Ghosh; Xufen Yu; Heather L Osswald; Johnson Agniswamy; Yuan-Fang Wang; Masayuki Amano; Irene T Weber; Hiroaki Mitsuya
Journal:  J Med Chem       Date:  2015-06-24       Impact factor: 7.446

5.  Design, synthesis, X-ray studies, and biological evaluation of novel BACE1 inhibitors with bicyclic isoxazoline carboxamides as the P3 ligand.

Authors:  Arun K Ghosh; Koena Ghosh; Margherita Brindisi; Emma K Lendy; Yu-Chen Yen; Nagaswamy Kumaragurubaran; Xiangping Huang; Jordan Tang; Andrew D Mesecar
Journal:  Bioorg Med Chem Lett       Date:  2018-06-26       Impact factor: 2.823

6.  In silico screening of potential β-secretase (BACE1) inhibitors from VIETHERB database.

Authors:  Nguyen Thao Nhung; Nhung Duong; Huong Thi Thu Phung; Quan V Vo; Nguyen Minh Tam
Journal:  J Mol Model       Date:  2022-02-14       Impact factor: 1.810

7.  Identification of human ABAD inhibitors for rescuing Aβ-mediated mitochondrial dysfunction.

Authors:  Koteswara R Valaasani; Qinru Sun; Gang Hu; Jianping Li; Fang Du; Yaopeng Guo; Emily A Carlson; Xueqi Gan; Shirley S Yan
Journal:  Curr Alzheimer Res       Date:  2014-02       Impact factor: 3.498

Review 8.  The structural evolution of β-secretase inhibitors: a focus on the development of small-molecule inhibitors.

Authors:  Stefania Butini; Simone Brogi; Ettore Novellino; Giuseppe Campiani; Arun K Ghosh; Margherita Brindisi; Sandra Gemma
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

Review 9.  BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease.

Authors:  Arun K Ghosh; Heather L Osswald
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

10.  Structure based design, synthesis, pharmacophore modeling, virtual screening, and molecular docking studies for identification of novel cyclophilin D inhibitors.

Authors:  Koteswara Rao Valasani; Jhansi Rani Vangavaragu; Victor W Day; Shirley ShiDu Yan
Journal:  J Chem Inf Model       Date:  2014-02-28       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.